ADBIOTECH Co.,Ltd.
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
179530 | KO
Overview
Corporate Details
- ISIN(s):
- KR7179530001
- LEI:
- Country:
- South Korea
- Address:
- 강원도 춘천시 동내면 거두단지1길 39, 춘천시
- Website:
- http://www.adbiotech.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ADBIOTECH Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and sale of next-generation immune antibodies. The company's core technology is based on Immunoglobulin Y (IgY), producing specific antibodies from eggs as alternatives to conventional vaccines and antibiotics. Its product portfolio serves diverse markets, including livestock, aquaculture, and human health, with commercialized products sold both domestically and internationally. ADBIOTECH is actively expanding its R&D pipeline to include human therapies, such as Helico IgY and Cholesterol IgY, and is entering the global companion animal market with its proprietary VHH (nanobody) technology. The company manages the entire value chain from research to production and sales, positioning itself as a leader in the IgY technology field.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
|
Korean | 31.7 KB | ||
| 2025-09-15 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 133.2 KB | ||
| 2025-09-15 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 81.3 KB | ||
| 2025-08-29 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 68.2 KB | ||
| 2025-08-29 00:00 |
M&A Activity
[기재정정]경영권변경등에관한계약체결
|
Korean | 17.2 KB | ||
| 2025-08-22 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 105.4 KB | ||
| 2025-08-22 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
|
Korean | 102.6 KB | ||
| 2025-08-22 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 95.8 KB | ||
| 2025-08-22 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
|
Korean | 29.0 KB | ||
| 2025-08-22 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주명부폐쇄기간또는기준일설정
|
Korean | 7.6 KB | ||
| 2025-08-22 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 132.6 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-08-14 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
|
Korean | 35.8 KB | ||
| 2025-08-14 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 129.8 KB | ||
| 2025-08-14 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 81.6 KB |
Automate Your Workflow. Get a real-time feed of all ADBIOTECH Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ADBIOTECH Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ADBIOTECH Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
